Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

2012 Third Quarter Revenue


PR Newswire/Les Echos/

PRESS RELEASE

Sèvres, October 30, 2012


                          2012 Third-quarter Revenue

*  Revenue surged 17.1% in the third quarter and 17.2% over the first nine
   months of the year
*  Growth in Africa (80% of revenue) came to 23% (in the third quarter and over
   the first nine months of the year)

In a statement, Alain Viry, Chairman of CFAO's Management Board said:
"CFAO's excellent performances in Africa - up 23% - confirm the strength of the
Group's strategy and its leading position in its businesses.
Two major acquisitions for the future development of Eurapharma were carried out
recently: one in Nigeria, the main pharmaceutical market in Sub-Saharan Africa,
and the other with Missionpharma, the world leader in medical kits.
The change in primary shareholder which is currently underway with the
acquisition by Toyota Tsusho Corporation (TTC) of an interest in CFAO marks the
beginning of a new period which will see not only the continuation of our
current strategy, but also new development opportunities in CFAO's markets. This
is the spirit of TTC's publicly expressed intentions in relation to its
investment in CFAO.
Based on the current market climate, we can look forward to the final quarter of
2012 with confidence and confirm our aim to achieve revenue growth in excess of
12% and a recurring operating margin of above 8.0% in 2012."

Throughout this press release, "like-for-like" changes correspond to changes
observed on a constant Group structure and exchange rate basis.
                                    Third-quarter         
                         2011     2012      Change       Change       

(in EURm) (in EURm) (reported) (like-for-like) CFAO Automotive 468.4 556.4 +18.8% +15.3% Eurapharma 220.2 250.4 +13.7% +2.5% CFAO Industries, Equipment & 89.6 104.8 +16.8% +14.1% Services Group total 778.3 911.5 +17.1% +11.4%

Nine months ended September 30

2011 2012 Change Change

(in EURm) (in EURm) (reported) (like-for-like)


         1,370.3    1,635.6    +19.4%        +16.0%
       639.1      710.6    +11.2%         +6.1%
       255.5      308.4    +20.7%        +18.2%

2,264.8 2,654.6 +17.2% +13.4%

Changes in Group structure had a positive impact on revenue in both the third quarter and the first nine months of the year, of EUR27.9 million and EUR52.3 million, respectively. In the third quarter, the most significant change related to the first-time consolidation of Missionpharma (in the Eurapharma division). Exchange rate fluctuations had a positive EUR12.3 million impact on the translation of third-quarter revenue into euros, in particular in Kenya and in Nigeria. The cumulative currency effect for the nine months ended September 30, 2012 was a positive EUR23.4 million.

CFAO posted third-quarter revenue of EUR911.5 million, up sharply by 17.1% on a reported basis and 11.4% like-for-like compared with the same prior-year period. For the first nine months of 2012, revenue totaled EUR2,654.6 million, climbing 17.2% on a reported basis and 13.4% like-for-like. Excluding Côte d'Ivoire, which was subject to significant unrest in 2011, revenue advanced 15.5% on a reported basis and 11.7% like-for-like.

CFAO Automotive reported robust sales growth in all geographic areas, with the exception of the French overseas territories where business was slow with markets retreating 5% overall in the first nine months of the year. Business continued to grow in French-speaking Sub-Saharan Africa despite a slight slowdown in several countries in the region. Sales were up in English-speaking Africa, particularly in Kenya, Zambia and Tanzania, but were flat in Nigeria due to a market contraction of 13% in the first nine months of the year. The Algerian market, however, continued to gather momentum enabling CFAO Automotive to post a sharp upward trend in sales in the country. The yen, the division's main purchasing currency, and the US dollar remained strong throughout the third quarter (the average euro to yen and euro to US dollar exchange rates were 98.3 and 1.25, respectively).

Eurapharma's pharmaceutical products distribution business recorded third-quarter revenue of EUR250.4 million, up 13.7% on a reported basis and 2.5% like-for-like. In the first nine months of 2012, revenue was up 11.2% on a reported basis. French-speaking Sub-Saharan Africa suffered a slight slowdown in growth, while business remained very brisk in English- and Portuguese-speaking Sub-Saharan Africa with positive contributions from all countries. Business is also expanding in Algeria where the Group now imports and manufactures pharmaceutical products.

Revenue for CFAO Industries, Equipment & Services came in at EUR104.8 million in third-quarter 2012, up 16.8% as reported on the same prior-year period and 14.1% like-for-like. Revenue growth for the Industries business (beverages and plastic products) remained high with the ongoing ramp-up in the new equipment distribution and rental services businesses. Due to completion delays on several projects, the Technologies business recorded a slight dip in revenue over the quarter. Nevertheless, several orders have been taken for new business offerings (outsourcing, audit, radio services, geolocation).

Financial position at September 30, 2012

At end-September 2012, the Group's financial position remained solid, despite an increase in net debt due to higher inventory levels, in particular at CFAO Automotive.

Significant events On August 2, 2012, the Japanese group TTC acquired 29.8% of CFAO's share capital, taking over part of PPR's interest in the company. TTC filed a draft tender offer for the remaining CFAO shares on September 14, 2012. The AMF issued a visa relating to TTC's information document and CFAO's response document on October 16. The documents entitled "Information relating, in particular, to the legal, financial and accounting characteristics" of TTC and CFAO were filed with the AMF on October 17, 2012. The offer has been open since October 19, 2012. The quarter also saw the consolidation of Missionpharma, the world leader in medical kits, which has extensive operations in Africa.

Outlook for 2012

CFAO confirms the information provided in the document entitled "Information relating, in particular, to the legal, financial and accounting characteristics of CFAO" which was filed with the AMF on October 17, 2012 and in particular, Group's aim to achieve revenue growth in excess of 12% and a recurring operating margin in excess of 8.0% in 2012.

The financial information in this press release is provided in compliance with IFRS and has not been audited. It has been reviewed by the Supervisory Board. This press release represents the Company's quarterly financial information. A presentation of this information is also available on the Company's website, www.cfaogroup.com.

This document contains forward-looking information, based on current assessments and estimates made by CFAO's management. These statements do not constitute guarantees relating to the Company's future performance. The information may change based on various factors, risks and uncertainties which may result in future publications being materially different from these forward- looking statements. These risk factors are described in CFAO's 2011 Reference Document filed with the AMF on April 6, 2012, in CFAO's Interim Financial Report for the six months ended June 30, 2012 published on July 26, 2012 and in other public documents filed with the AMF, in particular CFAO's information document in response to TTC's tender offer for CFAO's shares (AMF visa No. 12-494 dated October 16, 2012) and the document entitled "Information relating, in particular, to the legal, financial and accounting characteristics of CFAO" filed with the AMF on October 17, 2012. CFAO does not make any commitment to update or comment on forward-looking information, except for that which is required by applicable regulations. CFAO does not make any commitment to update or comment on forward-looking information, except for that which is required by applicable regulations.

About CFAO

CFAO is the foremost specialized retail brand in its main business areas - vehicle and pharmaceuticals distribution - in Africa and the French overseas territories. In Africa, CFAO also distributes equipment, produces and distributes consumer goods and is a provider of a number of technology-related services. CFAO is present in 34 countries, 31 of which are in Africa, and seven French overseas territories, and had a headcount of 10,100 at end-2011. In 2011, CFAO generated consolidated revenue of EUR3,124 million and recorded recurring operating income of EUR256.3 million. CFAO is listed on NYSE Euronext in Paris and is included in the SBF120 and CAC Mid 60 indices. Find CFAO on Bloomberg: CFAO:FP and Reuters: CFAO.PA To find out more, go to www.cfaogroup.com

Press Relations Laurence Tovi Director of Communications +33 1 46 23 58 80

Investor and Analyst Relations Sébastien Desarbres Director of Financial Communications and Investor Relations +33 1 46 23 56 51


                                   APPENDIX

Revenue trends by geographic area
                                      Third-quarter         
                         2011     2012      Change       Change       

(in EURm) (in EURm) (reported) (like-for-like) French- speaking Sub- 314.9 338.0 +7.3% +6.0% Saharan Africa English- speaking Sub- 98.8 134.9 +36.5% +11.8% Saharan Africa(*) Algeria and Morocco 136.5 203.3 +48.9% +44.9% French Overseas 183.8 179.1 -2.6% -1.1% Territories and Vietnam(*) Other Europe(**) 44.4 56.3 +26.8% -3.5% Total 778.3 911.5 +17.1% +11.4%

Nine months ended September 30

2011 2012 Change Change

(in EURm) (in EURm) (reported) (like-for-like)


         889.0     997.5        +12.2%        +11.0%
     287.1     377.8        +31.6%        +14.0%
     437.2    605.4         +38.5%        +35.4%
     534.4    534.4          +0.0%         +0.0%
     117.1    139.6         +19.2%          9.4%

2,264.8 2,654.6 +17.2% +13.4%

(*) CFAO Automotive Mauritius was shown in "French Overseas Territories and Other" until 2011, and is included in "English-and Portuguese-speaking Sub-Saharan Africa" in 2012. (**) France (export) and Denmark (Missionpharma)

The content and accuracy of news releases published on this site and/or distributed by PR Newswire or its partners are the sole responsibility of the originating company or organisation. Whilst every effort is made to ensure the accuracy of our services, such releases are not actively monitored or reviewed by PR Newswire or its partners and under no circumstances shall PR Newswire or its partners be liable for any loss or damage resulting from the use of such information. All information should be checked prior to publication.

-0- Oct/31/2012 08:07 GMT

Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement